AMLN (DIABETES DRUGS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (793)	9/12/1997 12:57:00 PM
From: D.Right	of 2173

Dear Henry: Unlike yourself, to discuss investment issues based on a rumor is not my expertise. However, I will comment anyway just to make you happy. If the rumor turns out to be true (God bless you), it will remind investors that LGND is about three years behind AMLN in developing its diabetic drug. As I pointed out in post #625 on this thread that pramlintide is working via a unique mecnhanism which is the first in its class with no competition anywhere. Yor read and responded to that specific post. However, you are trying to spread this rumor of how pramlintide will be taken down by an non-competitive frug which is many years away from getting to the patients. You talked about the potential off-label use of LGND's not-yet approved drug before, but, after the fen-phen incidence, people should know the danger of what off-label use can lead to. Again, LGND is a good company in many ways but not necessary in the diabetic area yet. There are many ways to promote your interests, spread rumor is the worst, it will never work. It seems to me you have no interest to discuss AMLN other than putting it down. I hope you did not short AMLN. That would be a bad mistake. Good luck D.Right

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next